23% stake heldStrategic acquisitionMaterials & ChemicalsCompleted
Novonesis completes MicroBioGen acquisition
Novonesis closed its acquisition of Australian yeast biotechnology firm MicroBioGen, building on a 23% stake held since 2013; all regulatory approvals were obtained.
Read the full coverage, free
We only link to sources you can read without a subscription. How we check.
Following materials and chemicals M&A?
The next big materials and chemicals deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.
See what you get →